skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia

Rapid Communication

(2786) Views  (1592) Full article downloads

Authors: Terry Golombick, Terry Diamond

Published Date March 2008 Volume 2008:2(1) Pages 161 - 163
DOI: http://dx.doi.org/10.2147/BTT.S2514

Terry Golombick, Terry Diamond

Department of Endocrinology, St George Hospital, Kogarah, Australia

Abstract: Plasma cell dyscrasias, most commonly associated with paraproteinemia, are a diverse group of diseases. Monoclonal gammopathy of undefined significance (MGUS) can precede multiple myeloma, a progressive neoplastic disease. MGUS occurs in association with a variety of other diseases and currently no treatment is recommended but rather “watchful waiting”. Given that the size of the M-protein is a risk factor for disease progression, early intervention with the aim of reducing the paraprotein load would provide an innovative therapeutic tool. Preliminary results from our pilot study show a drop of between 5% and 30% serum paraprotein in patients taking curcumin compared with patients on placebo. Curcumin is a diferuloylmethane present in extracts of the rhizome of the Curcuma longa plant. As a natural product, this has exciting potential in the treatment of plasma cell dyscrasias.

Keywords: plasma cell dyscrasias, MGUS, myeloma, curcumin, paraproteinemia






 

Other articles by Dr Terry Golombick

The effect of a combined oral calcium and vitamin D supplement for treating mild to moderate vitamin D deficiency in postmenopausal women
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed